Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:10 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study
NCT00526071 · Amicus Therapeutics · PHASE2 · terminated · last registry update 2018-10-03 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The Sponsor (Amicus Therapeutics) terminated this study for logistical reasons.” | – | Registry record, Amicus Therapeutics |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against GLA within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2019-08-08Phase 3 first posted: Amicus Therapeutics, migalastat HCl 150 mg (NCT04049760)
- 2019-07-15Phase 3 first posted: Amicus Therapeutics, migalastat HCl 150 mg (NCT04020055)
- 2018-11-09Phase 3 first posted: Idorsia Pharmaceuticals Ltd., Lucerastat (NCT03737214)
- 2018-11-01Results posted on the registry: Amicus Therapeutics, Migalastat HCl + Agalsidase Beta (NCT01196871)
- 2018-11-01Results posted on the registry: Amicus Therapeutics, migalastat hydrochloride + agalsidase (NCT01218659)
- 2018-10-30Results posted on the registry: Amicus Therapeutics, migalastat hydrochloride + Placebo (NCT00925301)
- 2018-10-02Results posted on the registry: Amicus Therapeutics, migalastat hydrochloride (NCT01458119)
- 2018-10-02Also stopped (terminated): Amicus Therapeutics, migalastat hydrochloride (NCT01458119)
- 2018-09-07Results posted on the registry: Amicus Therapeutics, migalastat HCl (NCT00283959)
- 2018-09-07Results posted on the registry: Amicus Therapeutics, migalastat HCl (NCT00214500)
- 2018-09-07Results posted on the registry: Amicus Therapeutics, migalastat HCl (NCT00304512)
- 2018-09-07Results posted on the registry: Amicus Therapeutics, migalastat HCl (NCT00283933)
- 2018-04-17Phase 3 first posted: Amicus Therapeutics, Migalastat HCl 150 mg (NCT03500094)
- 2018-02-07Phase 3 first posted: Idorsia Pharmaceuticals Ltd., Lucerastat + Placebo (NCT03425539)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision